Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18f-choline pet/ct

International Journal of Radiation Oncology Biology Physics

Volumn 91, Issue 5, 2015, Pages 1017-1025

  Kuang, Yu ^a   Wu, Lili ^a,b   Hirata, Emily ^c   Miyazaki, Kyle ^c   Sato, Miles ^c   Kwee, Sandi A ^c,d  

^a UNIVERSITY OF NEVADA   (United States)

^b CANCER HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^c QUEEN S MEDICAL CENTER   (United States)

^d UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; POSITRON EMISSION TOMOGRAPHY; PROBABILITY DISTRIBUTIONS; RADIOTHERAPY; TOXICITY; TRANSMISSION CONTROL PROTOCOL; TUMORS;

DOSE-VOLUME HISTOGRAMS; LOCALIZED PROSTATE CANCER; NORMAL TISSUE COMPLICATION PROBABILITIES; NORMAL-TISSUE TOXICITY; PLANNING TARGET VOLUMES; POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHIES; TUMOR CONTROL PROBABILITY; VOLUMETRIC MODULATED ARC THERAPY;

UROLOGY;

CHOLINE C 11; CHOLINE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; CHOLINE; FLUORINE; FLUOROMETHYLCHOLINE;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOSIMETRY; DRUG UPTAKE; FEMUR HEAD; HISTOGRAM; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INTRAPROSTATICALLY DOMINANT LESION; MALE; NORMAL TISSUE COMPLICATION PROBABILITY; ORGANS AT RISK; PRESCRIPTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROBABILITY; PROSTATE; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIOLOGICAL PARAMETERS; RADIOTHERAPY PLANNING SYSTEM; RECTUM; RECTUM HEMORRHAGE; SENSITIVITY AND SPECIFICITY; TOXICITY; TUMOR CONTROL PROBABILITY; TUMOR VOLUME; VOLUMETRIC MODULATED ARC THERAPY; VOLUMETRY; ALPHA RADIATION; ANALOGS AND DERIVATIVES; BLADDER; DIAGNOSTIC IMAGING; ELECTRON; FEASIBILITY STUDY; FEMORAL HEAD; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; MIDDLE AGED; MULTIMODAL IMAGING; PATHOLOGY; PENIS; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; PROSTATIC NEOPLASMS; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY;

AGED; AGED, 80 AND OVER; ALPHA PARTICLES; BETA PARTICLES; CHOLINE; FEASIBILITY STUDIES; FEMUR HEAD; FLUORINE RADIOISOTOPES; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; ORGANS AT RISK; PENIS; POSITRON-EMISSION TOMOGRAPHY; PROSTATE; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, IMAGE-GUIDED; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN; URINARY BLADDER;

EID: 84925336849     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.12.052     Document Type: Article

References (46)

1. P.A. Kupelian, J. Ciezki, and C.A. Reddy Effect of increasing radiation doses on local and distant failures in patients with localized prostate cancer Int J Radiat Oncol Biol Phys 71 2008 16 22
2. M.J. Zelefsky, X. Pei, and J.F. Chou Dose escalation for prostate cancer radiotherapy: Predictors of long-term biochemical tumor control and distant metastases-free survival outcomes Eur Urol 60 2011 1133 1139
3. G.A. Viani, E.J. Stefano, and S.L. Afonso Higher-than-conventional radiation doses in localized prostate cancer treatment: A meta-analysis of randomized, controlled trials Int J Radiat Oncol Biol Phys 74 2009 1405 1418
4. D.E. Spratt, X. Pei, and J. Yamada Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer Int J Radiat Oncol Biol Phys 85 2013 686 692
5. N. Cellini, A.G. Morganti, and G.C. Mattiucci Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: Implications for conformal therapy planning Int J Radiat Oncol Biol Phys 53 2002 595 599
6. D. Pucar, H. Hricak, and A. Shukla-Dave Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: Magnetic resonance imaging and step-section pathology evidence Int J Radiat Oncol Biol Phys 69 2007 62 69
7. C.M. Nutting, C.M. Corbishley, and B. Sanchez-Nieto Potential improvements in the therapeutic ratio of prostate cancer irradiation: Dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy Br J Radiol 75 2002 151 161
8. G. Bauman, M. Haider, and U.A. Van der Heide Boosting imaging defined dominant prostatic tumors: A systematic review Radiother Oncol 107 2013 274 281
9. C.C. Huang, F.M. Deng, and M.X. Kong Re-evaluating the concept of "dominant/index tumor nodule" in multifocal prostate cancer Virchows Arch 464 2014 589 594
10. V. Mouraviev, A. Villers, and D.G. Bostwick Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: Active surveillance and focal targeted therapy BJU Int 108 2011 1074 1085
11. K. Glunde, Z.M. Bhujwalla, and S.M. Ronen Choline metabolism in malignant transformation Nat Rev Cancer 11 2011 835 848
12. T. Yamaguchi, J. Lee, and H. Uemura Prostate cancer: A comparative study of 11c-choline PET and MR imaging combined with proton MR spectroscopy Eur J Nucl Med Mol Imaging 32 2005 742 748
13. S.A. Kwee, T.R. DeGrado, and J.N. Talbot Cancer imaging with fluorine-18-labeled choline derivatives Semin Nucl Med 37 2007 420 428
14. M. Piert, H. Park, and A. Khan Detection of aggressive primary prostate cancer with 11c-choline PET/CT using multimodality fusion techniques J Nucl Med 50 2009 1585 1593
15. S.A. Kwee, G.P. Thibault, and R.S. Stack Use of step-section histopathology to evaluate 18f-fluorocholine PET sextant localization of prostate cancer Mol Imaging 7 2008 12 20
16. 11C-choline positron emission tomography scans Int J Radiat Oncol Biol Phys 83 2012 e691 e696
17. 18F-choline PET-CT to define a simultaneous integrated boost Strahlenther Onkol 186 2010 600 606
18. 18)F-choline PET-CT detected simultaneous integrated boost Radiat Oncol 7 2012 14
19. E.M. Quan, X. Li, and Y. Li A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment Int J Radiat Oncol Biol Phys 83 2012 1169 1178
20. P. Ost, B. Speleers, and G. De Meerleer Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: A planning comparison study Int J Radiat Oncol Biol Phys 79 2011 920 926
21. J. Mohler, R.R. Bahnson, and B. Boston NCCN clinical practice guidelines in oncology: Prostate cancer J Natl Compr Cancer Netw 8 2010 162 200
22. Michalski J, Purdy J, Bruner D, et al. A phase III randomized study of high dose 3DCRT/IMRT versus standard dose 3DCRT/IMRT in patients treated for localized prostate cancer. RTOG 0126 Protocol Information. Available at: http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0126.
23. 18F-fluorocholine PET J Nucl Med 47 2006 262 269
24. J.H. Chang, D.L. Joon, and S.T. Lee Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapy Radiother Oncol 99 2011 187 192
25. L.J. Murray, J. Lilley, and C.M. Thompson Prostate stereotactic ablative radiation therapy using volumetric modulated arc therapy to dominant intraprostatic lesions Int J Radiat Oncol Biol Phys 89 2014 406 415
26. J. Uzan, and A.E. Nahum Radiobiologically guided optimisation of the prescription dose and fractionation scheme in radiotherapy using biosuite Br J Radiol 85 2012 1279 1286
27. A. Nahum, and B. Sanchez-Nieto Tumour control probability modelling: Basic principles and applications in treatment planning Physica Medica 17 2001 13 23
28. J.T. Lyman Complication probability as assessed from dose-volume histograms Radiat Res Suppl 8 1985 S13 S19
29. G.J. Kutcher, and C. Burman Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method Int J Radiat Oncol Biol Phys 16 1989 1623 1630
30. A. Niemierko Reporting and analyzing dose distributions: A concept of equivalent uniform dose Med Phys 24 1997 103 110
31. J.M. Michalski, H. Gay, and A. Jackson Radiation dose-volume effects in radiation-induced rectal injury Int J Radiat Oncol Biol Phys 76 2010 S123 129
32. C. Burman, G.J. Kutcher, and B. Emami Fitting of normal tissue tolerance data to an analytic function Int J Radiat Oncol Biol Phys 21 1991 123 135
33. 18F-choline PET-CT detected simultaneous integrated boost Radiother Oncol 93 2009 213 219
34. R.M. D'Angelillo, R. Sciuto, and S. Ramella (18)F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: Feasibility study in 60 patients Int J Radiat Oncol Biol Phys 90 2014 296 302
35. L.B. Marks, E.D. Yorke, and A. Jackson Use of normal tissue complication probability models in the clinic Int J Radiat Oncol Biol Phys 76 2010 S10 19
36. Z.A. Alicikus, Y. Yamada, and Z. Zhang Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer Cancer 117 2011 1429 1437
37. J. Seppala, M. Seppanen, and E. Arponen Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer Radiother Oncol 93 2009 234 240
38. S.F. Riches, G.S. Payne, and N.M. Desouza Effect on therapeutic ratio of planning a boosted radiotherapy dose to the dominant intraprostatic tumour lesion within the prostate based on multifunctional MR parameters Br J Radiol 87 2014 20130813
39. P.L. Nguyen, M.-H. Chen, and Y. Zhang Updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk prostate cancer: Implications for focal therapy J Urol 188 2012 1151 1156
40. J. Vainshtein, E. Abu-Isa, and K. Olson Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: Implications for focal therapy Radiat Oncol 7 2012 82
41. R. Miralbell, M. Mollà, and M. Rouzaud Hypofractionated boost to the dominant tumor region with intensity modulated stereotactic radiotherapy for prostate cancer: A sequential dose escalation pilot study Int J Radiat Oncol Biol Phys 78 2010 50 57
42. R. Miralbell, and F. Buchegger PET/CT imaging and the oligometastatic prostate cancer patient: An opportunity for a curative approach with high-dose radiotherapy? Eur J Nucl Med Mol Imaging 41 2014 1267 1269
43. U. Schick, Y. Popowski, and P. Nouet High-dose-rate brachytherapy boost to the dominant intra-prostatic tumor region: Hemi-irradiation of prostate cancer Prostate 71 2011 1309 1316
44. D.T. Schmid, H. John, and R. Zweifel Fluorocholine PET/CT in patients with prostate cancer: Initial experience Radiology 235 2005 623 628
45. 18F-fluorocholine for prostate cancer imaging: A systematic review of the literature Prostate Cancer Prostatic Dis 15 2012 45 55
46. B. Tareen, G. Godoy, and A. Sankin Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer? BJU Int 104 2009 195 199